Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 4
1968 6
1969 2
1970 5
1971 6
1972 5
1973 7
1974 9
1975 1
1976 7
1977 5
1978 9
1979 2
1980 8
1981 4
1982 2
1991 1
2001 1
2002 1
2003 2
2004 3
2005 2
2006 6
2007 3
2008 9
2009 9
2010 5
2011 3
2012 5
2013 5
2014 10
2015 8
2016 2
2017 9
2018 9
2019 9
2020 19
2021 8
2022 19
2023 16
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Results by year

Filters applied: . Clear all
Page 1
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis.
Agrawal R, Testi I, Bodaghi B, Barisani-Asenbauer T, McCluskey P, Agarwal A, Kempen JH, Gupta A, Smith JR, de Smet MD, Yuen YS, Mahajan S, Kon OM, Nguyen QD, Pavesio C, Gupta V; Collaborative Ocular Tuberculosis Study Consensus Group. Agrawal R, et al. Ophthalmology. 2021 Feb;128(2):277-287. doi: 10.1016/j.ophtha.2020.06.052. Epub 2020 Jun 27. Ophthalmology. 2021. PMID: 32603726
Editorial: Next Therapeutic Targets in Ocular Diseases.
Yanai R, Okunuki Y, Park DH, Zunaina E. Yanai R, et al. Front Med (Lausanne). 2022 Jun 23;9:953377. doi: 10.3389/fmed.2022.953377. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35814755 Free PMC article. No abstract available.
New Insights Into Immunological Therapy for Retinal Disorders.
Takeda A, Yanai R, Murakami Y, Arima M, Sonoda KH. Takeda A, et al. Among authors: yanai r. Front Immunol. 2020 Jul 3;11:1431. doi: 10.3389/fimmu.2020.01431. eCollection 2020. Front Immunol. 2020. PMID: 32719682 Free PMC article. Review.
Current practice in the management of ocular toxoplasmosis.
Yogeswaran K, Furtado JM, Bodaghi B, Matthews JM; International Ocular Toxoplasmosis Study Group; Smith JR. Yogeswaran K, et al. Br J Ophthalmol. 2023 Jul;107(7):973-979. doi: 10.1136/bjophthalmol-2022-321091. Epub 2022 Feb 23. Br J Ophthalmol. 2023. PMID: 35197262
[Pathophysiology and new treatment of uveitis].
Yanai R, Takeda A, Yoshimura T, Sonoda KH. Yanai R, et al. Nihon Rinsho Meneki Gakkai Kaishi. 2014;37(2):74-82. doi: 10.2177/jsci.37.74. Nihon Rinsho Meneki Gakkai Kaishi. 2014. PMID: 24835134 Free article. Review. Japanese.
Advances in treatment for neurotrophic keratopathy.
Nishida T, Yanai R. Nishida T, et al. Among authors: yanai r. Curr Opin Ophthalmol. 2009 Jul;20(4):276-81. doi: 10.1097/icu.0b013e32832b758f. Curr Opin Ophthalmol. 2009. PMID: 19537364 Review.
233 results